Titan Medical loses clinical & regulatory EVP Fowler
Titan Medical (CVE:TMD) said today that its executive vice president for clinical & regualtory affairs, Dr. Dennis Fowler, plans to resign effective August 31.
Toronto-based robot-assisted surgery company Titan, which is grappling with the suspension of its product development program, said Fowler’s duties will be divided on an interim basis between qualitry director James Shore and corporate accounts VP Christopher Seibert. Shore will assume responsibility for regulatory and Seibert will take on the project manager role for the Sport device, the company said, noting that Fowler “is willing to be available to Titan as a consultant.”
“I have enjoyed leading the development of the SPORT Surgical System and believe that it has significant potential for both clinical and economic success,” Fowler said in prepared remarks.
“On behalf of the Board of Directors and entire Titan team, I’d like to thank Dr. Fowler for his contributions to the development of the SPORT™ Surgical System and wish him the best in his future endeavors,” added CEO John Hargrove. Read more
Don’t miss the rest of MassDevice.com’s Personnel Moves – click the page numbers below to read more.
The post Titan Medical loses clinical & regulatory EVP Fowler | Personnel Moves for August 29, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/2c3zrFH
Cap comentari:
Publica un comentari a l'entrada